Hearings, Meetings, Proceedings, etc.: Initiation of Section 301 Investigations; Germany's Persistent Underpayment for Innovative Pharmaceutical Products
RulemakingNoticeUSTR_FRDOC_0001-0941
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 24, 2026
- Comment period
- Jun 24, 2026 – ?
- Agency
- Office of the United States Trade Representative (USTR)
- FR Doc
- 2026-12671
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.